Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates

Twist Bioscience (TWST) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.86 per share a year ago. These figures

Huntsman's Earnings and Revenues Lag Estimates in Q2, Down Y/Y
Huntsman's Earnings and Revenues Lag Estimates in Q2, Down Y/Y

Huntsman Corporation’s HUN second-quarter 2025 loss (as reported) was 92 cents per share. This compares to earnings of 13 cents per share in the year-ago quarter.  Barring one-time items, adjusted

BioCryst Pharmaceuticals (BCRX) Surpasses Q2 Earnings and Revenue Estimates
BioCryst Pharmaceuticals (BCRX) Surpasses Q2 Earnings and Revenue Estimates

BioCryst Pharmaceuticals (BCRX) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to a loss of $0.06 per share a year ago

Krystal Biotech, Inc. (KRYS) Tops Q2 Earnings and Revenue Estimates
Krystal Biotech, Inc. (KRYS) Tops Q2 Earnings and Revenue Estimates

Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $1.29 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $0.86 per share a year ago

How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?
How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?

AbbVie ABBV delivered encouraging second-quarter 2025 results last week, sending a clear message — it is effectively managing its post-Humira transition. The stronger-than-expected sales of newer

Bruker (BRKR) Misses Q2 Earnings Estimates
Bruker (BRKR) Misses Q2 Earnings Estimates

Bruker (BRKR) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.52 per share a year ago. These figures are

TG Therapeutics (TGTX) Misses Q2 Earnings Estimates
TG Therapeutics (TGTX) Misses Q2 Earnings Estimates

TG Therapeutics (TGTX) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.04 per share a year ago. These

Wayfair (W) Tops Q2 Earnings and Revenue Estimates
Wayfair (W) Tops Q2 Earnings and Revenue Estimates

Wayfair (W) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.47 per share a year ago. These figures are

Axsome Therapeutics (AXSM) Reports Q2 Loss, Beats Revenue Estimates
Axsome Therapeutics (AXSM) Reports Q2 Loss, Beats Revenue Estimates

Axsome Therapeutics (AXSM) came out with a quarterly loss of $0.92 per share versus the Zacks Consensus Estimate of a loss of $1. This compares to a loss of $1.24 per share a year ago. These figures

Why Robinhood Just Added Upside Potential After a Q2 Earnings Dip
Why Robinhood Just Added Upside Potential After a Q2 Earnings Dip

Although the vaunted S&P 500 Index recently snubbed Robinhood Markets (NASDAQ: HOOD), it remains one of the most impressive large-cap stocks of 2025. This comes despite the company’s latest

Canadian Natural to Report Q2 Earnings: What's in the Offing?
Canadian Natural to Report Q2 Earnings: What's in the Offing?

Canadian Natural Resources Limited CNQ is set to release second-quarter 2025 results on Aug. 7. The Zacks Consensus Estimate for earnings is pegged at 44 cents per share on revenues of $6.28

Hagerty, Inc. (HGTY) Tops Q2 Earnings and Revenue Estimates
Hagerty, Inc. (HGTY) Tops Q2 Earnings and Revenue Estimates

Hagerty, Inc. (HGTY) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.12 per share a year ago. These

Cheniere Energy to Report Q2 Earnings: What's in the Offing?
Cheniere Energy to Report Q2 Earnings: What's in the Offing?

Cheniere Energy, Inc. LNG is set to release second-quarter results on Aug. 7. The Zacks Consensus Estimate for earnings is $2.30 per share on revenues of $4.1 billion.

Let us delve into the factors

APA Corporation Q2 Earnings on Deck: Here's How It Will Fare
APA Corporation Q2 Earnings on Deck: Here's How It Will Fare

APA Corporation APA is set to release second-quarter results on Aug. 6. The bottom-line estimate for the to-be-reported quarter is pegged at a profit of 45 cents on revenues of $2.07 billion.

Let us

Zions Lifts Quarterly Dividend by 5%: Can it Keep Up the Pace?
Zions Lifts Quarterly Dividend by 5%: Can it Keep Up the Pace?

Zions Bancorporation ZION has announced a quarterly dividend of 45 cents per share, marking an increase of 5% from the prior payout. The dividend will be paid out on Aug. 21 to shareholders as of

3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio
3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio

It is never too late to invest in mutual funds for retirement. As such, if you plan to invest in some of the best funds, the Zacks Mutual Fund Rank can provide you with valuable guidance.

How can

Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?
Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?

Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.

The best way to shortlist great

NiSource to Release Q2 Earnings: What's in Store for the Stock?
NiSource to Release Q2 Earnings: What's in Store for the Stock?

NiSource NI is scheduled to release second-quarter 2025 results on Aug. 6, before market open. The company delivered an earnings surprise of 8.9% in the last reported quarter. Let’s discuss the

4 Utility Stocks Poised to Outperform in the Upcoming Earnings Cycle
4 Utility Stocks Poised to Outperform in the Upcoming Earnings Cycle

The Zacks Utilities sector’s second-quarter 2025 earnings are expected to have continued to benefit from new electric, natural gas and water rates, cost-saving initiatives and customer growth. The

GILD Likely to Beat on Q2 Earnings: Buy, Sell or Hold the Stock?
GILD Likely to Beat on Q2 Earnings: Buy, Sell or Hold the Stock?

Biotech bigwig Gilead Sciences, Inc. (GILD) is scheduled to report second-quarter 2025 results on Aug. 7, after market close. The Zacks Consensus Estimate for sales and earnings is pegged at $6.95

Freshpet (FRPT) Tops Q2 Earnings Estimates
Freshpet (FRPT) Tops Q2 Earnings Estimates

Freshpet (FRPT) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to a loss of $0.03 per share a year ago. These figures are

Idexx Laboratories (IDXX) Tops Q2 Earnings and Revenue Estimates
Idexx Laboratories (IDXX) Tops Q2 Earnings and Revenue Estimates

Idexx Laboratories (IDXX) came out with quarterly earnings of $3.63 per share, beating the Zacks Consensus Estimate of $3.31 per share. This compares to earnings of $2.44 per share a year ago. These

Baker Hughes & Chart Ink $13.6B Deal—Start of Energy's Comeback?
Baker Hughes & Chart Ink $13.6B Deal—Start of Energy's Comeback?

As the Q2 earnings season continues, the stock market is revealing that some sectors appear more promising than others. The energy sector is quickly taking the lead, offering the best

SiriusPoint (SPNT) Q2 Earnings and Revenues Top Estimates
SiriusPoint (SPNT) Q2 Earnings and Revenues Top Estimates

SiriusPoint (SPNT) came out with quarterly earnings of $0.66 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.57 per share a year ago. These

CNA Financial (CNA) Q2 Earnings and Revenues Surpass Estimates
CNA Financial (CNA) Q2 Earnings and Revenues Surpass Estimates

CNA Financial (CNA) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $0.94 per share. This compares to earnings of $1.19 per share a year ago. These